{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T09:04:50Z","timestamp":1785143090138,"version":"3.55.0"},"reference-count":98,"publisher":"American Chemical Society (ACS)","issue":"11","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Akademie Ved Cesk? Republiky","award":["86652036"],"award-info":[{"award-number":["86652036"]}]},{"name":"Ministerstvo ?kolstv?, Ml?de?e a Telov?chovy","award":["LUAUS23247"],"award-info":[{"award-number":["LUAUS23247"]}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health (NIH)","doi-asserted-by":"crossref","award":["R01CA249248"],"award-info":[{"award-number":["R01CA249248"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Tumor-associated macrophages (TAMs) play a pivotal role in shaping the tumor microenvironment (TME) and influencing the outcomes of immunotherapy. However, most drug screening strategies emphasize tumor cell cytotoxicity and neglect immune effector modulation. Here, we describe a macrophage-centric phenotypic screening platform to identify selective HDAC6 inhibitors that reprogram TAMs toward an antitumor phenotype. Building on the HDAC6 inhibitor SS-208, we synthesized a novel class of tetrazolone-based compounds with potent selectivity and minimal cytotoxicity. Among these, SM-06-09 emerged as a lead candidate, showing subnanomolar HDAC6 inhibition, enhanced macrophage phagocytosis, antigen presentation, and T-cell activation in vitro. In a syngeneic melanoma model, SM-06-09 suppressed tumor growth and promoted M1-like TAM polarization. Combination with anti-PD-1 therapy further enhanced immune infiltration, increased effector memory and central memory T-cells, and improved antitumor efficacy. This study establishes a functional screening framework for identifying immunomodulatory compounds and supports the clinical potential of macrophage-targeted HDAC6 inhibitors as adjuncts to immune checkpoint blockade.<\/jats:p>","DOI":"10.1021\/acs.jmedchem.5c02453","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T12:01:51Z","timestamp":1780056111000},"page":"12870-12897","source":"Crossref","is-referenced-by-count":0,"title":["Macrophage-Centric\nPhenotypic Screening Identifies\nTetrazolone-Based HDAC6 Inhibitors That Reprogram the Tumor Immune\nMicroenvironment and Improve Immune Checkpoint Blockade"],"prefix":"10.1021","volume":"69","author":[{"given":"Nithya","family":"Gajendran","sequence":"first","affiliation":[{"name":"Georgetown University , , ,","place":["Washington, District of Columbia, United States, 20057"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1285-0374","authenticated-orcid":true,"given":"Manasa","family":"Suresh","sequence":"additional","affiliation":[{"name":"Georgetown University , , ,","place":["Washington, District of Columbia, United States, 20057"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian J.","family":"Marquez R.","sequence":"additional","affiliation":[{"name":"University of Illinois Chicago , , ,","place":["Chicago, Illinois, United States, 60607"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sruthi","family":"Mohan","sequence":"additional","affiliation":[{"name":"University of Illinois Chicago , , ,","place":["Chicago, Illinois, United States, 60607"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Ponsot","sequence":"additional","affiliation":[{"name":"University of Illinois Chicago , , ,","place":["Chicago, Illinois, United States, 60607"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Quiceno-Torres","sequence":"additional","affiliation":[{"name":"Georgetown University , , ,","place":["Washington, District of Columbia, United States, 20057"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario A.","family":"Noboa","sequence":"additional","affiliation":[{"name":"University of Illinois Chicago , , ,","place":["Chicago, Illinois, United States, 60607"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3214-5090","authenticated-orcid":true,"given":"Bryan T.","family":"Weselman","sequence":"additional","affiliation":[{"name":"Georgetown University , , ,","place":["Washington, District of Columbia, United States, 20057"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xintang","family":"Li","sequence":"additional","affiliation":[{"name":"Georgetown University , , ,","place":["Washington, District of Columbia, United States, 20057"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Durr","sequence":"additional","affiliation":[{"name":"Georgetown University , , ,","place":["Washington, District of Columbia, United States, 20057"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9804-6346","authenticated-orcid":true,"given":"Zora","family":"Novakova","sequence":"additional","affiliation":[{"name":"BIOCEV , , Prumyslova 595 , ,","place":["Vestec, Czech Republic, 252 50"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0919-7076","authenticated-orcid":true,"given":"Mike","family":"Schutkowski","sequence":"additional","affiliation":[{"name":"Martin-Luther-University of Halle-Wittenberg , , ,","place":["Halle (Saale), Germany, 06120"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matias","family":"Hepp","sequence":"additional","affiliation":[{"name":"Universidad Cato\u0301lica de la Santi\u0301sima Concepcio\u0301n , , ,","place":["Concepcio\u0301n, Chile, 2850"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satish","family":"Noonepalle","sequence":"additional","affiliation":[{"name":"Georgetown University , , ,","place":["Washington, District of Columbia, United States, 20057"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2751-3060","authenticated-orcid":true,"given":"Cyril","family":"Barinka","sequence":"additional","affiliation":[{"name":"BIOCEV , , Prumyslova 595 , ,","place":["Vestec, Czech Republic, 252 50"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1234-5626","authenticated-orcid":true,"given":"Duncan J.","family":"Wardrop","sequence":"additional","affiliation":[{"name":"University of Illinois Chicago , , ,","place":["Chicago, Illinois, United States, 60607"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Villagra","sequence":"additional","affiliation":[{"name":"Georgetown University , , ,","place":["Washington, District of Columbia, United States, 20057"]},{"name":"Universidad Cato\u0301lica de la Santi\u0301sima Concepcio\u0301n , , ,","place":["Concepcio\u0301n, Chile, 2850"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"2026072621092911500_cit1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.critrevonc.2018.05.009","article-title":"Manipulating macrophage polarization and function using\nclassical HDAC inhibitors: Implications for autoimmunity and inflammation","volume":"128","author":"Mohammadi","year":"2018","journal-title":"Crit Rev. Oncol. Hematol."},{"issue":"6","key":"2026072621092911500_cit2","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/s41577-019-0127-6","article-title":"Macrophages as regulators\nof tumour immunity and immunotherapy","volume":"19","author":"DeNardo","year":"2019","journal-title":"Nat. Rev.\nImmunol."},{"issue":"7","key":"2026072621092911500_cit3","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","article-title":"Tumour-associated\nmacrophages as treatment targets in oncology","volume":"14","author":"Mantovani","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"11","key":"2026072621092911500_cit4","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1111\/exd.13089","article-title":"Inhibition\nof histone deacetylases in melanoma-a perspective from bench to bedside","volume":"25","author":"Hornig","year":"2016","journal-title":"Exp. Dermatol."},{"issue":"1","key":"2026072621092911500_cit5","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-024-02982-4","article-title":"Targeting HDAC6 improves\nanti-CD47\nimmunotherapy","volume":"43","author":"Gracia-Hernandez","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"12","key":"2026072621092911500_cit6","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1158\/1535-7163.MCT-20-0454","article-title":"A Precision\nMedicine Drug Discovery Pipeline Identifies Combined CDK2 and 9 Inhibition\nas a Novel Therapeutic Strategy in Colorectal Cancer","volume":"19","author":"Somarelli","year":"2020","journal-title":"Mol. Cancer Ther."},{"issue":"3","key":"2026072621092911500_cit7","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/s41568-024-00779-3","article-title":"PDX models for functional\nprecision oncology and discovery science","volume":"25","author":"Blanchard","year":"2025","journal-title":"Nat.\nRev. Cancer"},{"issue":"4","key":"2026072621092911500_cit8","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.it.2019.02.003","article-title":"Targeting\nTumor-Associated Macrophages\nin Cancer","volume":"40","author":"Pathria","year":"2019","journal-title":"Trends Immunol."},{"key":"2026072621092911500_cit9","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.576946","article-title":"The Roles\nof Histone Deacetylases\nand Their Inhibitors in Cancer Therapy","volume":"8","author":"Li","year":"2020","journal-title":"Front.\nCell Dev. Biol."},{"issue":"1","key":"2026072621092911500_cit10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13148-018-0602-0","article-title":"Epigenetic\ntherapy for ovarian cancer: promise and progress","volume":"11","author":"Moufarrij","year":"2019","journal-title":"Clin. Epigenetics"},{"issue":"13","key":"2026072621092911500_cit11","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1007\/s00018-012-0921-9","article-title":"Multiple roles of class I HDACs in\nproliferation, differentiation, and development","volume":"69","author":"Reichert","year":"2012","journal-title":"Cell. Mol. Life Sci."},{"key":"2026072621092911500_cit12","doi-asserted-by":"publisher","first-page":"831","DOI":"10.2741\/s303","article-title":"Modulation of cell\ncycle regulators by HDACs","volume":"4","author":"Telles","year":"2012","journal-title":"Front. Biosci."},{"issue":"1","key":"2026072621092911500_cit13","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/icb.2011.88","article-title":"HDAC inhibitors:\nmodulating leukocyte differentiation, survival, proliferation and\ninflammation","volume":"90","author":"Sweet","year":"2012","journal-title":"Immunol. Cell Biol."},{"issue":"1","key":"2026072621092911500_cit14","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/icb.2011.96","article-title":"Modulation\nof antigen-presenting cells by HDAC inhibitors: implications in autoimmunity\nand cancer","volume":"90","author":"Woan","year":"2012","journal-title":"Immunol. Cell Biol."},{"key":"2026072621092911500_cit15","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41392-019-0095-0","article-title":"Targeting\nepigenetic regulators for cancer therapy:\nmechanisms and advances in clinical trials","volume":"4","author":"Cheng","year":"2019","journal-title":"Signal Transduction Targeted Ther."},{"key":"2026072621092911500_cit16","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.578770","article-title":"Histone Deacetylases and Histone Deacetylase Inhibitors\nin Neuroblastoma","volume":"8","author":"Phimmachanh","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"5","key":"2026072621092911500_cit17","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1093\/emboj\/cdg115","article-title":"HDAC-6 interacts\nwith and deacetylates tubulin and\nmicrotubules in vivo","volume":"22","author":"Zhang","year":"2003","journal-title":"EMBO J."},{"issue":"2","key":"2026072621092911500_cit18","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s43018-022-00494-8","article-title":"HDAC6 score: to treat or not to treat?","volume":"4","author":"Hey","year":"2023","journal-title":"Nat. Cancer"},{"issue":"1","key":"2026072621092911500_cit19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-42237-3","article-title":"Selective HDAC6 inhibitors improve anti-PD-1 immune\ncheckpoint blockade therapy by decreasing the anti-inflammatory phenotype\nof macrophages and down-regulation of immunosuppressive proteins in\ntumor cells","volume":"9","author":"Knox","year":"2019","journal-title":"Sci. Rep."},{"issue":"46","key":"2026072621092911500_cit20","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adp3687","article-title":"The HDAC6\ninhibitor\nAVS100 (SS208) induces a pro-inflammatory tumor microenvironment and\npotentiates immunotherapy","volume":"10","author":"Kovalovsky","year":"2024","journal-title":"Sci. Adv."},{"issue":"17","key":"2026072621092911500_cit21","doi-asserted-by":"publisher","first-page":"3649","DOI":"10.1158\/0008-5472.CAN-19-3738","article-title":"HDAC6 Plays a Noncanonical Role in\nthe Regulation of Antitumor Immune Responses, Dissemination, and Invasiveness\nof Breast Cancer","volume":"80","author":"Banik","year":"2020","journal-title":"Cancer Res."},{"issue":"12","key":"2026072621092911500_cit22","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1158\/1535-7163.MCT-23-0215","article-title":"Radiotherapy-induced\nImmune Response Enhanced by Selective HDAC6 Inhibition","volume":"22","author":"Noonepalle","year":"2023","journal-title":"Mol. Cancer Ther."},{"key":"2026072621092911500_cit23","doi-asserted-by":"publisher","first-page":"462","DOI":"10.18632\/oncotarget.28607","article-title":"The advances\nin targeting CD47\/SIRP\u03b1\n\u201cdo not eat me\u201d axis and their ongoing challenges as\nan anticancer therapy","volume":"15","author":"Gracia-Hernandez","year":"2024","journal-title":"Oncotarget"},{"issue":"9","key":"2026072621092911500_cit24","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1093\/neuonc\/noz089","article-title":"A large-scale drug screen identifies\nselective inhibitors of class I HDACs as a potential therapeutic option\nfor SHH medulloblastoma","volume":"21","author":"Pak","year":"2019","journal-title":"Neuro-Oncology"},{"issue":"22","key":"2026072621092911500_cit25","doi-asserted-by":"publisher","first-page":"15171","DOI":"10.1021\/acs.jmedchem.3c01095","article-title":"Discovery of Selective Histone Deacetylase 1 and 2\nInhibitors: Screening of a Focused Library Constructed by Click Chemistry,\nKinetic Binding Analysis, and Biological Evaluation","volume":"66","author":"Itoh","year":"2023","journal-title":"J. Med. Chem."},{"issue":"21","key":"2026072621092911500_cit26","doi-asserted-by":"publisher","first-page":"12460","DOI":"10.1021\/acs.jmedchem.0c00830","article-title":"Thirty years\nof HDAC inhibitors:\n2020 insight and hindsight","volume":"63","author":"Ho","year":"2020","journal-title":"J. Med. Chem."},{"issue":"13","key":"2026072621092911500_cit27","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1016\/S0960-894X(97)00284-9","article-title":"Analogues of trichostatin\nA and trapoxin B as histone deacetylase inhibitors","volume":"7","author":"Jung","year":"1997","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"18","key":"2026072621092911500_cit28","doi-asserted-by":"publisher","first-page":"8557","DOI":"10.1021\/acs.jmedchem.9b00946","article-title":"Discovery\nof a new isoxazole-3-hydroxamate-based\nhistone deacetylase 6 inhibitor SS-208 with antitumor activity in\nsyngeneic melanoma mouse models","volume":"62","author":"Shen","year":"2019","journal-title":"J. Med. Chem."},{"issue":"1","key":"2026072621092911500_cit29","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/cmdc.201500456","article-title":"Identification of HDAC6-selective inhibitors of low\ncancer cell cytotoxicity","volume":"11","author":"Gaisina","year":"2016","journal-title":"ChemMedChem"},{"issue":"4","key":"2026072621092911500_cit30","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1021\/acs.jmedchem.5b01493","article-title":"Synthesis and biological\ninvestigation of oxazole hydroxamates as highly selective histone\ndeacetylase 6 (HDAC6) inhibitors","volume":"59","author":"Senger","year":"2016","journal-title":"J. Med. Chem."},{"key":"2026072621092911500_cit31","doi-asserted-by":"crossref","unstructured":"Bar\u030cinka C.; Motlova L.; Pavlicek J. X-ray structure of Danio rerio histone deacetylase 6 (HDAC6) CD2 in complex with an inhibitor SS208. Protein Data Bnak, 2019, entry 6R0K. 10.2210\/pdb6R0K.pdb.","DOI":"10.2210\/pdb6r0k\/pdb"},{"issue":"9","key":"2026072621092911500_cit32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0044498","article-title":"Oral administration of the pimelic\ndiphenylamide HDAC inhibitor HDACi 4b is unsuitable for chronic inhibition\nof HDAC activity in the CNS in vivo","volume":"7","author":"Beconi","year":"2012","journal-title":"PLoS One"},{"issue":"21","key":"2026072621092911500_cit33","doi-asserted-by":"publisher","first-page":"12290","DOI":"10.1021\/acs.jmedchem.0c00530","article-title":"Amide bond bioisosteres:\nStrategies, synthesis, and successes","volume":"63","author":"Kumari","year":"2020","journal-title":"J. Med.\nChem."},{"issue":"39","key":"2026072621092911500_cit34","doi-asserted-by":"publisher","first-page":"9343","DOI":"10.1039\/C6OB01646D","article-title":"Tetrazolone\nas an acid\nbioisostere: application to marketed drugs containing a carboxylic\nacid","volume":"14","author":"Duncton","year":"2016","journal-title":"Org. Biomol. Chem."},{"issue":"39","key":"2026072621092911500_cit35","doi-asserted-by":"publisher","first-page":"9338","DOI":"10.1039\/C6OB01644H","article-title":"A one-pot synthesis\nof tetrazolones from acid chlorides:\nunderstanding functional group compatibility, and application to the\nlate-stage functionalization of marketed drugs","volume":"14","author":"Duncton","year":"2016","journal-title":"Org. Biomol. Chem."},{"issue":"12","key":"2026072621092911500_cit36","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1021\/acsmedchemlett.3c00336","article-title":"Tuning the reactivity of nuclear\nfactor erythroid 2-related\nfactor 2 (Nrf2) activators for optimal in vivo efficacy","volume":"14","author":"Markovtsov","year":"2023","journal-title":"ACS Med. Chem. Lett."},{"issue":"8","key":"2026072621092911500_cit37","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1107\/S0108270198002108","article-title":"1H-Tetrazol-5(4H)-one","volume":"54","author":"Ohno","year":"1998","journal-title":"Acta Crystallogr., Sect.\nC: Cryst. Struct. Commun."},{"issue":"9","key":"2026072621092911500_cit38","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1039\/b823041b","article-title":"Intermolecular\ninteractions in the\ncrystal structures of substituted tetrazolones","volume":"11","author":"Rayat","year":"2009","journal-title":"CrystEngComm"},{"issue":"18","key":"2026072621092911500_cit39","doi-asserted-by":"publisher","first-page":"13135","DOI":"10.1021\/acs.jmedchem.3c01147","article-title":"Discovery of 12 (BMS-986172) as a\nhighly potent MGAT2 inhibitor that achieved targeted efficacious exposures\nat a low human dose for the treatment of metabolic disorders","volume":"66","author":"Meng","year":"2023","journal-title":"J. Med. Chem."},{"issue":"23","key":"2026072621092911500_cit40","doi-asserted-by":"publisher","first-page":"10711","DOI":"10.1021\/acs.jmedchem.9b01194","article-title":"Novel benzohydroxamate-based potent and selective histone\ndeacetylase 6 (HDAC6) inhibitors bearing a pentaheterocyclic scaffold:\nDesign, synthesis, and biological evaluation","volume":"62","author":"Vergani","year":"2019","journal-title":"J. Med. Chem."},{"issue":"11","key":"2026072621092911500_cit41","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.1021\/acs.orglett.8b01118","article-title":"Multicomponent synthesis\nand binding mode of imidazo[1,2- a]pyridine-capped selective HDAC6\ninhibitors","volume":"20","author":"Mackwitz","year":"2018","journal-title":"Org. Lett."},{"key":"2026072621092911500_cit42","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114470","article-title":"Selective\ninhibition of histone deacetylase 3 by novel hydrazide based small\nmolecules as therapeutic intervention for the treatment of cancer","volume":"238","author":"Pulya","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"2026072621092911500_cit43","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105274","article-title":"HDAC6 as privileged\ntarget in drug discovery: A perspective","volume":"163","author":"Pulya","year":"2021","journal-title":"Pharmacol.\nRes."},{"issue":"5\u20136","key":"2026072621092911500_cit44","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1515\/HC.1995.1.5-6.395","article-title":"Molecular orbital study\nof the fragmentation mechanism on 5-hydroxytetrazole","volume":"1","author":"Waki","year":"1995","journal-title":"Heterocycl. Commun."},{"issue":"5","key":"2026072621092911500_cit45","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/(SICI)1521-4087(199910)24:5&lt;319::AID-PREP319&gt;3.0.CO;2-K","article-title":"Theoretical Study on Tetrazole and\nits Derivatives:\n4. Ab Initio Study on Hydroxyl Derivatives of Tetrazole","volume":"24","author":"Zhaoxu","year":"1999","journal-title":"Propellants, Explos., Pyrotech."},{"issue":"8","key":"2026072621092911500_cit46","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2020.127023","article-title":"Structural\ndeterminants of affinity and selectivity\nin the binding of inhibitors to histone deacetylase 6","volume":"30","author":"Osko","year":"2020","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"10","key":"2026072621092911500_cit47","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.1002\/cber.19811141007","article-title":"Synthese und Photolyse\nvon 1,4-Dialkyl-1,4-dihydro-5H-tetrazol-5-onen\nund -thionen: Neue Wege zu Diaziridinonen und Carbodiimiden1)","volume":"114","author":"Quast","year":"1981","journal-title":"Chem. Ber."},{"issue":"9","key":"2026072621092911500_cit48","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/nchembio.2134","article-title":"Histone\ndeacetylase 6 structure and molecular basis\nof catalysis and inhibition","volume":"12","author":"Hai","year":"2016","journal-title":"Nat. Chem. Biol."},{"issue":"26","key":"2026072621092911500_cit49","doi-asserted-by":"publisher","first-page":"4352","DOI":"10.1002\/ejoc.200700276","article-title":"Isoxazoles and isoxazolines\nby 1,3-dipolar cycloaddition: Base-catalysed condensation of primary\nNitro compounds with dipolarophiles","volume":"2007","author":"Machetti","year":"2007","journal-title":"Eur. J.\nOrg. Chem."},{"issue":"12","key":"2026072621092911500_cit50","doi-asserted-by":"publisher","first-page":"4873","DOI":"10.1021\/jo050036f","article-title":"Improved solution- and solid-phase preparation of hydroxamic acids\nfrom esters","volume":"70","author":"Ho","year":"2005","journal-title":"J. Org. Chem."},{"issue":"10","key":"2026072621092911500_cit51","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/S1359-6446(04)03069-7","article-title":"Ligand efficiency:\na useful metric\nfor lead selection","volume":"9","author":"Hopkins","year":"2004","journal-title":"Drug Discovery Today"},{"issue":"6","key":"2026072621092911500_cit52","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1021\/ml500146d","article-title":"Validity\nof ligand efficiency metrics","volume":"5","author":"Murray","year":"2014","journal-title":"ACS Med. Chem.\nLett."},{"issue":"11","key":"2026072621092911500_cit53","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/nrd2445","article-title":"The influence of drug-like concepts on decision-making\nin medicinal chemistry","volume":"6","author":"Leeson","year":"2007","journal-title":"Nat. Rev. Drug Discovery"},{"issue":"3","key":"2026072621092911500_cit54","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1021\/acs.jmedchem.7b01404","article-title":"(N-hydroxycarbonylbenylamino)quinolines\nas selective histone deacetylase 6 inhibitors suppress growth of multiple\nmyeloma in vitro and in vivo","volume":"61","author":"Lee","year":"2018","journal-title":"J. Med. Chem."},{"issue":"17","key":"2026072621092911500_cit55","doi-asserted-by":"publisher","first-page":"8054","DOI":"10.1021\/acs.jmedchem.8b01013","article-title":"Histone deacetylase 6-selective inhibitors\nand the influence of capping groups on hydroxamate-zinc denticity","volume":"61","author":"Porter","year":"2018","journal-title":"J. Med. Chem."},{"issue":"5","key":"2026072621092911500_cit56","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1021\/acs.jmedchem.0c01922","article-title":"Unique molecular\ninteraction with\nthe histone deacetylase 6 catalytic tunnel: Crystallographic and biological\ncharacterization of a model chemotype","volume":"64","author":"Olaoye","year":"2021","journal-title":"J. Med.\nChem."},{"issue":"31","key":"2026072621092911500_cit57","doi-asserted-by":"publisher","first-page":"10842","DOI":"10.1021\/ja102758v","article-title":"Rational design and simple chemistry\nyield a superior,\nneuroprotective HDAC6 inhibitor, tubastatin A","volume":"132","author":"Butler","year":"2010","journal-title":"J. Am. Chem. Soc."},{"issue":"7","key":"2026072621092911500_cit58","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide:\na new approach for rapid, accurate docking and scoring. 1. Method\nand assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J. Med.\nChem."},{"issue":"21","key":"2026072621092911500_cit59","doi-asserted-by":"publisher","first-page":"6177","DOI":"10.1021\/jm051256o","article-title":"Extra precision\nglide: docking and scoring incorporating a model of hydrophobic enclosure\nfor protein-ligand complexes","volume":"49","author":"Friesner","year":"2006","journal-title":"J. Med. Chem."},{"issue":"3","key":"2026072621092911500_cit60","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: parameters, protocols,\nand influence on virtual screening enrichments","volume":"27","author":"Madhavi Sastry","year":"2013","journal-title":"J. Comput.-Aided Mol. Des."},{"issue":"12","key":"2026072621092911500_cit61","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.3390\/ph16121639","article-title":"A review on molecular docking on\nHDAC isoforms: Novel\ntool for designing selective inhibitors","volume":"16","author":"Drakontaeidi","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"51","key":"2026072621092911500_cit62","doi-asserted-by":"publisher","first-page":"13459","DOI":"10.1073\/pnas.1718823114","article-title":"Unusual\nzinc-binding mode of HDAC6-selective hydroxamate inhibitors","volume":"114","author":"Porter","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1","key":"2026072621092911500_cit63","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1021\/acs.jmedchem.9b01540","article-title":"Exploring\nstructural determinants of inhibitor affinity and selectivity in complexes\nwith histone deacetylase 6","volume":"63","author":"Osko","year":"2020","journal-title":"J. Med. Chem."},{"issue":"18","key":"2026072621092911500_cit64","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1021\/acs.biochem.2c00332","article-title":"Aromatic\nring fluorination patterns modulate inhibitory potency of fluorophenylhydroxamates\ncomplexed with histone deacetylase 6","volume":"61","author":"Watson","year":"2022","journal-title":"Biochemistry"},{"issue":"8","key":"2026072621092911500_cit65","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1021\/acs.accounts.3c00801","article-title":"Chemical\nversatility in catalysis and inhibition of the class IIb histone deacetylases","volume":"57","author":"Christianson","year":"2024","journal-title":"Acc. Chem. Res."},{"key":"2026072621092911500_cit66","doi-asserted-by":"publisher","first-page":"107072","DOI":"10.1016\/j.bioorg.2023.107072","article-title":"Groebke\nBlackburn Bienayme\u0301-mediated\nmulti-component synthesis of selective HDAC6 inhibitors with anti-inflammatory\nproperties","volume":"143","author":"Kraft","year":"2024","journal-title":"Bioorg. Chem."},{"issue":"5","key":"2026072621092911500_cit67","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1021\/acsmedchemlett.9b00560","article-title":"Structural and in vivo\ncharacterization of tubastatin A, a widely used histone deacetylase\n6 inhibitor","volume":"11","author":"Shen","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"issue":"1","key":"2026072621092911500_cit68","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1021\/acs.jmedchem.4c02341","article-title":"Discovery of N-phenyl-5-propyl-1H-pyrazole-3-carboxamide,\nwith selective\ninhibition and degradation of HDAC6 for the treatment of acute liver\ninjury","volume":"68","author":"Cui","year":"2025","journal-title":"J. Med. Chem."},{"key":"2026072621092911500_cit69","first-page":"245","article-title":"A synopsis\nof the properties and applications of heteroaromatic rings in medicinal\nchemistry","volume-title":"Advances in Heterocyclic Chemistry","author":"Meanwell","year":"2017"},{"issue":"4","key":"2026072621092911500_cit70","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/prot.10259","article-title":"Kinase inhibitors and the case for\nCH\u00b7\u00b7\u00b7O hydrogen bonds in protein-ligand binding","volume":"49","author":"Pierce","year":"2002","journal-title":"Proteins"},{"issue":"1","key":"2026072621092911500_cit71","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1021\/acs.jcim.6b00406","article-title":"On-the-fly QM\/MM docking with Attracting\nCavities","volume":"57","author":"Chaskar","year":"2017","journal-title":"J. Chem. Inf. Model."},{"issue":"2","key":"2026072621092911500_cit72","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/prot.26227","article-title":"A multiscale\napproach to predict\nthe binding mode of metallo beta-lactamase inhibitors","volume":"90","author":"Gervasoni","year":"2022","journal-title":"Proteins"},{"issue":"8","key":"2026072621092911500_cit73","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1021\/acschembio.0c00362","article-title":"Structural\nbasis for the selective inhibition of HDAC10, the cytosolic polyamine\ndeacetylase","volume":"15","author":"Herbst-Gervasoni","year":"2020","journal-title":"ACS Chem. Biol."},{"issue":"28","key":"2026072621092911500_cit74","doi-asserted-by":"publisher","first-page":"E2592","DOI":"10.1073\/pnas.1300113110","article-title":"Histone deacetylase\n10 promotes autophagy-mediated cell survival","volume":"110","author":"Oehme","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1","key":"2026072621092911500_cit75","doi-asserted-by":"publisher","DOI":"10.1186\/s12950-020-00267-z","article-title":"Inflammatory M1-like\nmacrophages polarized by NK-4 undergo enhanced phenotypic switching\nto an anti-inflammatory M2-like phenotype upon co-culture with apoptotic\ncells","volume":"18","author":"Kohno","year":"2021","journal-title":"J. Inflammation"},{"issue":"2","key":"2026072621092911500_cit76","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41416-020-01048-4","article-title":"Cytotoxic CD8(+) T\ncells in cancer and cancer immunotherapy","volume":"124","author":"Raskov","year":"2021","journal-title":"Br.\nJ. Cancer"},{"key":"2026072621092911500_cit77","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1295257","article-title":"Tumor-associated macrophages:\nan effective player of\nthe tumor microenvironment","volume":"14","author":"Basak","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"2026072621092911500_cit78","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-024-03182-w","article-title":"Cell therapy\nusing ex vivo reprogrammed macrophages enhances antitumor immune responses\nin melanoma","volume":"43","author":"Noonepalle","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"6","key":"2026072621092911500_cit79","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.tcb.2008.04.003","article-title":"HDAC6: a key\nregulator of cytoskeleton, cell migration and cell-cell interactions","volume":"18","author":"Valenzuela-Ferna\u0301ndez","year":"2008","journal-title":"Trends Cell Biol."},{"key":"2026072621092911500_cit80","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116930","article-title":"Macrophage polarization in the tumor\nmicroenvironment: Emerging roles\nand therapeutic potentials","volume":"177","author":"Zhang","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"2026072621092911500_cit81","doi-asserted-by":"publisher","DOI":"10.1186\/1757-2215-7-19","article-title":"A high M1\/M2 ratio\nof tumor-associated macrophages is associated\nwith extended survival in ovarian cancer patients","volume":"7","author":"Zhang","year":"2014","journal-title":"J. Ovarian Res."},{"issue":"11","key":"2026072621092911500_cit82","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41573-022-00520-5","article-title":"Macrophages as tools\nand targets in cancer therapy","volume":"21","author":"Mantovani","year":"2022","journal-title":"Nat. Rev. Drug\nDiscovery"},{"issue":"1","key":"2026072621092911500_cit83","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41698-024-00522-z","article-title":"Targeting M2-like tumor-associated\nmacrophages is a\npotential therapeutic approach to overcome antitumor drug resistance","volume":"8","author":"Wang","year":"2024","journal-title":"npj Precis. Oncol."},{"key":"2026072621092911500_cit84","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.961805","article-title":"Clinical cancer\nimmunotherapy: Current progress and prospects","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Immunol."},{"issue":"9","key":"2026072621092911500_cit85","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.3390\/ijms20092241","article-title":"Immunoepigenetics Combination\nTherapies:\nAn Overview of the Role of HDACs in Cancer Immunotherapy","volume":"20","author":"Banik","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"2026072621092911500_cit86","doi-asserted-by":"publisher","first-page":"4720","DOI":"10.3390\/ijms24054720","article-title":"Selectivity of Hydroxamate-\nand Difluoromethyloxadiazole-Based Inhibitors of Histone Deacetylase\n6 In Vitro and in Cells","volume":"24","author":"Ptacek","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"18","key":"2026072621092911500_cit87","doi-asserted-by":"publisher","first-page":"10246","DOI":"10.1021\/acs.jmedchem.0c00567","article-title":"Rational Design of Suprastat: A Novel Selective Histone\nDeacetylase 6 Inhibitor with the Ability to Potentiate Immunotherapy\nin Melanoma Models","volume":"63","author":"Noonepalle","year":"2020","journal-title":"J. Med. Chem."},{"issue":"8","key":"2026072621092911500_cit88","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/s41587-019-0201-4","article-title":"Graph-based\ngenome alignment and genotyping with HISAT2 and HISAT-genotype","volume":"37","author":"Kim","year":"2019","journal-title":"Nat. Biotechnol."},{"issue":"7","key":"2026072621092911500_cit89","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"featureCounts:\nan efficient general\npurpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinformatics"},{"issue":"12","key":"2026072621092911500_cit90","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated\nestimation of fold change\nand dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"2026072621092911500_cit91","unstructured":"Blighe, K.; R, S.; Lewis, M., EnhancedVolcano: Publication-ready\nvolcano plots with enhanced colouring and labeling. 2018."},{"issue":"3","key":"2026072621092911500_cit92","doi-asserted-by":"publisher","DOI":"10.1002\/cpz1.90","article-title":"Gene Set Knowledge\nDiscovery with Enrichr","volume":"1","author":"Xie","year":"2021","journal-title":"Curr. Protoc."},{"issue":"W1","key":"2026072621092911500_cit93","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","article-title":"Enrichr: a\ncomprehensive gene set enrichment analysis web server 2016 update","volume":"44","author":"Kuleshov","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"2026072621092911500_cit94","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-128","article-title":"Enrichr: interactive\nand collaborative HTML5 gene list enrichment analysis tool","volume":"14","author":"Chen","year":"2013","journal-title":"BMC Bioinf."},{"issue":"2","key":"2026072621092911500_cit95","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","article-title":"Dictionary learning for integrative, multimodal and\nscalable single-cell analysis","volume":"42","author":"Hao","year":"2024","journal-title":"Nat. Biotechnol."},{"issue":"2","key":"2026072621092911500_cit96","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","article-title":"Reference-based analysis of lung\nsingle-cell sequencing reveals a transitional profibrotic macrophage","volume":"20","author":"Aran","year":"2019","journal-title":"Nat. Immunol."},{"issue":"12","key":"2026072621092911500_cit97","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.it.2013.03.004","article-title":"Immunological Genome\nProject and systems immunology","volume":"34","author":"Shay","year":"2013","journal-title":"Trends Immunol."},{"issue":"4","key":"2026072621092911500_cit98","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nbt.2859","article-title":"The dynamics and regulators of cell fate decisions\nare revealed by pseudotemporal ordering of single cells","volume":"32","author":"Trapnell","year":"2014","journal-title":"Nat. Biotechnol."}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.5c02453","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/69\/11\/12870\/66168776\/acs.jmedchem.5c02453.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/69\/11\/12870\/66168776\/acs.jmedchem.5c02453.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T08:18:37Z","timestamp":1785140317000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article\/69\/11\/12870\/5201040\/Macrophage-Centric-Phenotypic-Screening-Identifies"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":98,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,5,29]]},"published-print":{"date-parts":[[2026,6,11]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.jmedchem.5c02453","relation":{},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]}}}